The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Stocks rose slightly on Tuesday, but gains were capped as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
The U.S. Air Force's top general says he has not yet received direction to send additional bombers to the Middle East after what is believed to be an Iranian attack on Saudi...Defenseread more
"I believe the path to 'health care for all' is a path following the lead of the Affordable Care Act," House Speaker Nancy Pelosi tells Jim Cramer.Health and Scienceread more
E-cigarette maker Juul Labs Inc.'s sales have been halted on two websites in China, just days after it launched in the world's biggest tobacco market.Biotech and Pharmaceuticalsread more
Investors might be wary that gasoline prices will continue to rise, and are looking to take back profits by selling off shares.Retailread more
The Trump administration move on California's auto emissions standards would likely set up a fight between the White House and the state.Politicsread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Brightcove: "Brightcove I think is a little risky. It's making a lot of money there and the stock has had a very big run. My take is don't buy, don't buy."
Sarepta Therapautics: "This is one of the highest risk stocks in the world. It's a binary stock; they either get approval or they don't. If they get approval, the stock has still doubled from $28. And if they don't get approval the stock can get crushed. I think it's way too risky for me."
Marathon Oil: "It's worked its way all the way back. I've got to hand it to them, but I've got to tell you we've got a couple of winners that I like more. We've got Pioneer and EOG if you want to be a little bit more speculative, and we've got Occidental which my charitable trust owns."
Ford: "I think you'll do fine in Ford. It's got a good yield, it's got a good balance sheet. The sales are just OK. The Chinese sales were quite impressive that were announced the other day, but I don't think the stock can run away."
Cliffs Natural Resources: "I think it's a little risky because it's had a run back. I know that a lot of people like Tech Resources, BHP and Rio. Those stocks were strong today, but Cliffs at $6? I don't know. A lot of things have to go right. I wouldn't sell it, but I certainly wouldn't buy anymore."